Associations between potential trigger foods and disease activity in patients with inflammatory bowel disease; a cross-sectional study
Introduction Patients with inflammatory bowel disease (IBD) often report one or more foods to cause or aggravate relapse, and tend to restrict intake of these foods. Some of the foods that patients avoid are suggested in the literature to demonstrate pro- or anti-inflammatory potential. Thus, we investigated whether IBD disease activity was associated with foods that patients report as relapse triggers considering their inflammation-related properties, macronutrients, and blood markers of nutritional status. Methods Patients with IBD ≥ 18 years from the IBSEN III (Inflammatory Bowel Disease in South-Eastern Norway) study completed a food frequency questionnaire covering habitual food intake the preceding year. Intake of food groups was either estimated through splitting foods down into their ingredients (method 1) or as consumed (method 2). Endoscopic indices and fecal calprotectin were applied to differentiate between inactive and active IBD. Multivariate logistic regression models were used to assess associations. Results A total of 301 patients with IBD were included. Most foods patients reported as triggers did not associate with IBD disease activity. Margarine intake associated with active IBD (OR 1.22, 95% CI 1.07–1.40), but lost significance in the endoscopy-only analysis OR 1.74 (95% CI 1.21, 2.51, p = 0.003), and no significant associations for macronutrients or blood markers of nutritional status. Conclusion Nearly all foods identified by patients as relapse triggers, regardless of their pro- or anti-inflammatory properties, showed no association with active IBD. These hypothesis-generating findings require confirmation in RCTs using objective disease-activity measures and more precise prospective dietary exposure assessment methods.
Authors
- Øivind Asak
- Petr Ricanek (ORCID: https://orcid.org/0000-0003-2454-7388)
- Christine Sommer (ORCID: https://orcid.org/0000-0002-7370-8988)
- Marte Lie Høivik (ORCID: https://orcid.org/0000-0002-0104-465X)
- Milada Hagen (ORCID: https://orcid.org/0000-0001-8947-8649)
- Gert Huppertz‐Hauss (ORCID: https://orcid.org/0000-0002-5693-8773)
- Tone Bergene Aabrekk (ORCID: https://orcid.org/0009-0007-4933-5580)
- Jørgen Valeur (ORCID: https://orcid.org/0000-0001-7193-7069)
- Monica Hauger Carlsen (ORCID: https://orcid.org/0000-0001-8324-1384)
- Vibeke Strande (ORCID: https://orcid.org/0009-0004-9121-6807)
- Anne‐Marie Aas (ORCID: https://orcid.org/0000-0002-9347-9633)
- Øistein Hovde (ORCID: https://orcid.org/0000-0003-4662-4153)
- Svein Oskar Frigstad (ORCID: https://orcid.org/0000-0001-7841-608X)
- Magne Henriksen (ORCID: https://orcid.org/0000-0002-8067-5838)
- Vendel Ailin Kristensen (ORCID: https://orcid.org/0000-0002-0876-8634)
- Charlotte Indre Lund (ORCID: https://orcid.org/0009-0006-5348-4645)
- May‐Bente Bengtson (ORCID: https://orcid.org/0000-0002-5615-7141)
- Randi Opheim (ORCID: https://orcid.org/0000-0002-0513-1435)
- Trond Espen Detlie (ORCID: https://orcid.org/0000-0002-1576-5298)
- Insaf Zerouga (ORCID: https://orcid.org/0009-0000-0609-0340)
- Raziye Boyar
Institutions
- Oslo University Hospital (NO)
- OsloMet – Oslo Metropolitan University (NO)
- University of Oslo (NO)
- Innlandet Hospital Trust (NO)
- Akershus University Hospital (NO)
- Vestre Viken Hospital Trust (NO)
- Sykehuset i Vestfold (NO)
- Diakonhjemmet Hospital (NO)
- Telemark Hospital (NO)
- Lovisenberg Diakonale Sykehus (NO)
- Østfold Hospital Trust (NO)
Publication Details
- Journal
- Frontiers in Nutrition
- Published
- 2026-11-17
- DOI
- https://doi.org/10.3389/fnut.2026.1889382
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- Tillotts Pharma
- Akershus Universitetssykehus
- Sykehuset Innlandet HF
- Sykehuset Telemark